Gabapentin Dosing Recommendations
Start gabapentin at 300 mg on day 1, increase to 600 mg/day on day 2, and 900 mg/day on day 3, then titrate to 1800 mg/day in three divided doses for neuropathic pain, with mandatory dose reductions based on creatinine clearance in renal impairment. 1
Neuropathic Pain (Postherpetic Neuralgia)
The FDA-approved dosing schedule is straightforward and evidence-based 1:
- Day 1: 300 mg once daily
- Day 2: 300 mg twice daily (600 mg/day)
- Day 3: 300 mg three times daily (900 mg/day)
- Target dose: 1800 mg/day (600 mg three times daily)
- Maximum dose: 3600 mg/day if needed
The 1800 mg/day dose is the optimal target - clinical trials demonstrated efficacy across 1800-3600 mg/day, but additional benefit above 1800 mg/day was not consistently demonstrated 1. The Mayo Clinic guideline confirms this approach, noting that adequate trials may require 2 months or more, with at least 2 weeks at maximum tolerated dose 2.
Doses should be given three times daily with maximum 12-hour intervals between doses 1.
Epilepsy (Adjunct Therapy for Partial Onset Seizures)
Adults and Children ≥12 years:
- Starting dose: 300 mg three times daily
- Maintenance dose: 300-600 mg three times daily
- Maximum: 2400 mg/day (well-tolerated in long-term studies); 3600 mg/day has been used short-term 1
Pediatric Patients (3-11 years):
- Starting dose: 10-15 mg/kg/day in three divided doses
- Titration: Increase over approximately 3 days
- Maintenance doses:
- Ages 3-4 years: 40 mg/kg/day in three divided doses
- Ages 5-11 years: 25-35 mg/kg/day in three divided doses
- Doses up to 50 mg/kg/day have been well-tolerated 1
Restless Legs Syndrome
For RLS with end-stage renal disease (ESRD), the AASM conditionally recommends gabapentin 3. However, specific dosing for RLS is not provided in the FDA label. The evidence suggests gabapentin enacarbil (a prodrug) at 600-1200 mg/day is effective, but standard gabapentin dosing for RLS should follow neuropathic pain protocols with careful titration 4, 5.
Renal Impairment Dosing (Critical)
Gabapentin is 100% renally excreted and MUST be dose-adjusted 1. Use the Cockcroft-Gault equation to estimate creatinine clearance:
| CrCl (mL/min) | Total Daily Dose | Dosing Regimen |
|---|---|---|
| ≥60 | 900-3600 mg/day | 300-1200 mg TID |
| 30-59 | 400-1400 mg/day | 200-700 mg BID |
| 15-29 | 200-700 mg/day | 200-700 mg once daily |
| <15 | 100-300 mg/day | 100-300 mg once daily |
Hemodialysis Patients:
- Base maintenance dose on CrCl as above
- Add supplemental post-dialysis dose: 125-350 mg after each 4-hour dialysis session 1
- Gabapentin half-life drops from 132 hours (non-dialysis days) to 3.8 hours during dialysis 1
Critical warning: Failure to adjust for renal function causes severe neurotoxicity, particularly myoclonus 6, 7. This is a common and devastating complication in patients with chronic kidney disease.
Elderly Patients
Reduce starting doses and slow titration in elderly patients 2, 1. Elderly patients have:
- Decreased renal function (CL/F drops from ~225 mL/min in <30 years to ~125 mL/min in >70 years) 1
- Higher risk of dizziness, somnolence, and falls
- Always calculate CrCl - don't rely on serum creatinine alone 1
Administration Details
- Take with or without food 1
- If using scored 600 mg or 800 mg tablets divided in half, use the other half as the next dose within 28 days 1
- Never stop abruptly - taper over minimum 1 week (longer if needed) 1
- Maximum time between doses: 12 hours 1
Common Pitfalls to Avoid
- Failing to adjust for renal function - this causes myoclonus and severe neurotoxicity 6, 7
- Stopping too early - adequate trials require 6-8 weeks with at least 2 weeks at maximum tolerated dose 2
- Inadequate titration - jumping to high doses causes intolerable dizziness and somnolence
- Not monitoring elderly patients - they require lower doses due to age-related renal decline 1
- Abrupt discontinuation - always taper over ≥1 week 1